These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21601332)

  • 1. Successful simultaneous liver-kidney transplant in an adult with atypical hemolytic uremic syndrome associated with a mutation in complement factor H.
    Wilson C; Torpey N; Jaques B; Strain L; Talbot D; Manas D; Goodship T
    Am J Kidney Dis; 2011 Jul; 58(1):109-12. PubMed ID: 21601332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful isolated liver transplantation in a child with atypical hemolytic uremic syndrome and a mutation in complement factor H.
    Haller W; Milford DV; Goodship TH; Sharif K; Mirza DF; McKiernan PJ
    Am J Transplant; 2010 Sep; 10(9):2142-7. PubMed ID: 20738267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
    Tran H; Chaudhuri A; Concepcion W; Grimm PC
    Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
    Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.
    Saland JM; Shneider BL; Bromberg JS; Shi PA; Ward SC; Magid MS; Benchimol C; Seikaly MG; Emre SH; Bresin E; Remuzzi G
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):201-6. PubMed ID: 19005013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient.
    Chan MR; Thomas CP; Torrealba JR; Djamali A; Fernandez LA; Nishimura CJ; Smith RJ; Samaniego MD
    Am J Kidney Dis; 2009 Feb; 53(2):321-6. PubMed ID: 18805611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.
    Saland JM; Ruggenenti P; Remuzzi G;
    J Am Soc Nephrol; 2009 May; 20(5):940-9. PubMed ID: 19092117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation.
    Kim S; Park E; Min SI; Yi NJ; Ha J; Ha IS; Cheong HI; Kang HG
    J Korean Med Sci; 2018 Jan; 33(1):e4. PubMed ID: 29215813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
    Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G
    Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H.
    Jalanko H; Peltonen S; Koskinen A; Puntila J; Isoniemi H; Holmberg C; Pinomäki A; Armstrong E; Koivusalo A; Tukiainen E; Mäkisalo H; Saland J; Remuzzi G; de Cordoba S; Lassila R; Meri S; Jokiranta TS
    Am J Transplant; 2008 Jan; 8(1):216-21. PubMed ID: 17973958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome.
    Weitz M; Amon O; Bassler D; Koenigsrainer A; Nadalin S
    Pediatr Nephrol; 2011 Aug; 26(8):1325-9. PubMed ID: 21556717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-kidney transplantation to cure atypical HUS: still an option post-eculizumab?
    Saland J
    Pediatr Nephrol; 2014 Mar; 29(3):329-32. PubMed ID: 24362724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.
    Davin JC; Gracchi V; Bouts A; Groothoff J; Strain L; Goodship T
    Am J Kidney Dis; 2010 Apr; 55(4):708-11. PubMed ID: 19854549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation for aHUS: still needed in the eculizumab era?
    Coppo R; Bonaudo R; Peruzzi RL; Amore A; Brunati A; Romagnoli R; Salizzoni M; Galbusera M; Gotti E; Daina E; Noris M; Remuzzi G
    Pediatr Nephrol; 2016 May; 31(5):759-68. PubMed ID: 26604087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option?
    Hirt-Minkowski P; Schaub S; Mayr M; Schifferli JA; Dickenmann M; Frémeaux-Bacchi V; Steiger J
    Nephrol Dial Transplant; 2009 Nov; 24(11):3548-51. PubMed ID: 19633317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation.
    Saland JM; Emre SH; Shneider BL; Benchimol C; Ames S; Bromberg JS; Remuzzi G; Strain L; Goodship TH
    Am J Transplant; 2006 Aug; 6(8):1948-52. PubMed ID: 16889549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term successful liver-kidney transplantation in a child with atypical hemolytic uremic syndrome caused by homozygous factor H deficiency.
    Gonzales E; Ulinski T; Habes D; Deschênes G; Frémeaux-Bacchi V; Bensman A
    Pediatr Nephrol; 2016 Dec; 31(12):2375-2378. PubMed ID: 27744619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable long-term outcomes of isolated liver transplantation in a child with atypical hemolytic uremic syndrome caused by a novel complement factor H mutation
.
    Cho H; Lee Y
    Clin Nephrol; 2017 Jul; 88(1):52-56. PubMed ID: 28502324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
    J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
    Vondrák K; Seeman T
    Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.